Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia.
Edgar Lik Wui TayKentaro HayashidaMao ChenWei-Hsien YinDuk-Woo ParkAshok SethHsien-Li KaoMao-Shin LinKay-Woon HoWacin BuddhariMann ChandavimolFabio-Enriques PosasQuang N NguyenWilliam KongM A RosliJimmy HonDoni FirmanMichael LeePublished in: Journal of cardiac surgery (2020)
The COVID-19 pandemic has impacted on the delivery of TAVI services to patients in Asia. This expert recommendation on best practices may be a useful guide to help TAVI teams during this period until a COVID-19 vaccine becomes widely available.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve
- ejection fraction
- aortic valve replacement
- end stage renal disease
- primary care
- healthcare
- transcatheter aortic valve replacement
- coronavirus disease
- newly diagnosed
- sars cov
- chronic kidney disease
- mental health
- peritoneal dialysis
- clinical practice
- heart failure
- prognostic factors
- patient reported
- health insurance